Rigel Pharmaceuticals

- NASDAQ:RIGL
Last Updated 2021-09-18
  • Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
  • Locations

    • South San Francisco CA
  • Total Funding (USD)

    130.0 million
  • Industries

    Real Estate, Mobile Apps, Software, Cyber Security, Internet
  • Security

    Type: ORD
    CUSIP: 766559603
    ISIN: US7665596034
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.